Research article · 6 Oct 2026
Conference abstractPublished 2021
Photobiomodulation (PBM) for (dry) AMD and Electroretinography (ERG)
New York Medical College, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Photobiomodulation (PBM) also known as low level light therapy is used to stimulate retinal cell function to reverse the progress of dry age related macular degeneration (AMD). Clinical trials in Europe has succeeded in EU approval and current retinal trials in the US are concluding with promising results. AMD is caused by mitochondrial dysfunction and oxidative stress. PBM works by the absorption of photons by photoreceptors in the targeted tissue. Once absorbed, secondary cellular effects include increases in energy production and changes in signaling modalities such as reactive oxygen species (ROS), nitric oxide (NO) and cellular Calcium. Heretofore there has been no treatment for dry AMD except the AREDS nutritional NIH approved. Wet AMD has been successfully managed with anti-vegf therapy with moderate success but only represents 10% of AMD. Currently studies are underway with PBM to treat wet AMD and diabetic retinopathy (DR) . With our rapidly ageing population AMD is the major cause of worldwide blindness. PMB provides hope. Lumithera has designed a modest treatment device (Valeda) that delivers the precise low light in the range of low red to almost infra-red. Repeated office visits are required as the effect slowly fades and must be restored periodically. Current studies in the USA have been using the Diopsys Electroretinogram system as the sole objective evidence of the results in addition to the subjective ones, contrast sensitivity and BCVA
Subjects
Ophthalmology & OptometryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Experimental Ophthalmology.
Short communication · 30 Aug 2026
Vision Science in the Modern Era: Integrating Neuroscience, Genetics, and Technology
Commentary · 3 Aug 2026
Emerging Frontiers in Experimental Ophthalmology: Innovations and Translational Challenges
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Experimental Ophthalmology
- SubjectOphthalmology & Optometry
- BylineArticles whose byline prints “Herbert L Gould”

